↓ Skip to main content

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions

Overview of attention for article published in Cold Spring Harbor Perspectives in Medicine, January 2018
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemoprevention in Prostate Cancer: Current Perspective and Future Directions
Published in
Cold Spring Harbor Perspectives in Medicine, January 2018
DOI 10.1101/cshperspect.a030494
Pubmed ID
Authors

J. Ricardo Rivero, Ian M. Thompson, Michael A. Liss, Dharam Kaushik

Abstract

Chemoprevention of prostate cancer aims to reduce the mortality as well as the public burden of overdetection, which increases anxiety, cost, and morbidity related to the disease. The role of 5-α-reductase inhibitors has been well investigated and shown to decrease the risk of prostate cancer. No current evidence exists to encourage the use of nutrients or vitamins as chemopreventive agents. The modulation of inflammation is one of the most promising targets for chemoprevention of prostate cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 10%
Lecturer > Senior Lecturer 1 5%
Student > Ph. D. Student 1 5%
Student > Master 1 5%
Researcher 1 5%
Other 2 10%
Unknown 12 60%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 10%
Medicine and Dentistry 2 10%
Computer Science 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Immunology and Microbiology 1 5%
Other 1 5%
Unknown 12 60%